Clarius Group LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,824
Closed -$182K 511
2022
Q4
$182K Sell
23,824
-6,926
-23% -$52.9K 0.02% 487
2022
Q3
$219K Buy
30,750
+3,610
+13% +$25.7K 0.02% 424
2022
Q2
$220K Buy
27,140
+16,461
+154% +$133K 0.02% 415
2022
Q1
$300K Hold
10,679
0.02% 359
2021
Q4
$300K Sell
10,679
-20,000
-65% -$562K 0.02% 359
2021
Q3
$1.04M Hold
30,679
0.09% 119
2021
Q2
$1.25M Buy
30,679
+5,679
+23% +$232K 0.11% 108
2021
Q1
$1.01M Hold
25,000
0.1% 108
2020
Q4
$1.48M Sell
25,000
-4,596
-16% -$272K 0.16% 73
2020
Q3
$1.44M Hold
29,596
0.18% 60
2020
Q2
$1.43M Hold
29,596
0.2% 61
2020
Q1
$822K Sell
29,596
-10,000
-25% -$278K 0.16% 79
2019
Q4
$1.17M Buy
+39,596
New +$1.17M 0.19% 66